cancer
Gastroenterology, Oncology
A recent study demonstrated causation between microbial DCA metabolism and anti-tumor CD8+ T cell response in colorectal cancer.
Oncology
The findings of a recent study suggest that L. johnsonii or its metabolite IPA could be used as a microbial-based approach to improve a person’s response to immunotherapy.
Gastroenterology, Oncology
Research done in mice shows that the mouth-dwelling bacterium Porphyromonas gingivalis can travel from the mouth to the pancreas, resulting in lesions that lead to cancer.
Gastroenterology, Events
Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.
Gastroenterology
The findings suggest that microbial metabolites can help to predict who is at increased risk of infection after liver transplant. The results may also help to inform microbiota-targeted therapies.
Gastroenterology, Events
Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.
Gastroenterology, Oncology
The findings of a recent study suggest that the crosstalk between gut microbes and the host’s immune system can influence the body’s defenses during cancer therapy.
Industry
MaaT Pharma indicates completion of patient recruitment for the Phase 2a RCT Evaluating MaaT013 in combination with immune checkpoint inhibitors in metastatic melanoma.
Oncology
The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.
Gastroenterology, Scientific research
Focusing on restoring microbial cross-feeding interactions emerges as a promising mechanism-informed strategy to reconstruct a healthy gut ecosystem.